Patents Assigned to SmithKline Beecham Corp.
-
Patent number: 7235371Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.Type: GrantFiled: July 21, 2005Date of Patent: June 26, 2007Assignees: Human Genome Sciences, Inc., SmithKline Beecham Corp.Inventors: Gregg A. Hastings, Mark D. Adams, Claire M. Fraser, Norman H. Lee, Ewen F. Kirkness, Judith A. Blake, Lisa M. Fitzgerald, Fred H. Drake, Maxine Gowan
-
Publication number: 20070027084Abstract: ITGL-TSP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ITGL-TSP polypeptides and polynucleotides in the design of protocols for the treatment of, angiogenic diseases (cancer, cancer metastasis, chronic inflammatory disorders, rheumatoid arthritis, atherosclerosis, macular degeneration, diabetic retmopathy), restenosis, Alzheimer's disease and tissue remodeling, among others, and diagnostic assays for such conditions.Type: ApplicationFiled: September 28, 2006Publication date: February 1, 2007Applicants: Human Genome Sciences, Inc., SmithKline Beecham Corp.Inventors: Zdenka Jonak, Stephen Trulli, James Fornwald, Jonathon Terrett, Gregg Hastings
-
Publication number: 20070026495Abstract: ITGL-TSP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ITGL-TSP polypeptides and polynucleotides in the design of protocols for the treatment of, angiogenic diseases (cancer, cancer metastasis, chronic inflammatory disorders, rheumatoid arthritis, atherosclerosis, macular degeneration, diabetic retmopathy), restenosis, Alzheimer's disease and tissue remodeling, among others, and diagnostic assays for such conditions.Type: ApplicationFiled: September 28, 2006Publication date: February 1, 2007Applicants: Human Genome Sciences, Inc., SmithKline Beecham Corp.Inventors: Zdenka Jonak, Stephen Trulli, James Fornwald, Jonathan Terrett, Gregg Hastings
-
Patent number: 7132262Abstract: The present invention relates to methods and compositions useful in the treatment and prevention of human papilloma virus infections and the symptoms and diseases associated therewith. More particularly, the invention relates to polynucleotide sequences which encode human papilloma virus (HPV) amino acid amino acid sequences, wherein the codon usage pattern of the polynucleotide sequences resemble those of highly expressed mammalian genes.Type: GrantFiled: July 30, 2003Date of Patent: November 7, 2006Assignee: SmithKline Beecham Corp.Inventors: Peter Franz Ertl, Gerald Wayne Gough, Christopher Jeffrey Alan Ring, Vanita Parmar, Sarah Marina Walcott
-
Patent number: 7067280Abstract: Nucleic acid sequences for HC gp-39L are provided. Methods of detecting altered expression of tissue remodeling proteins and diagnosing tissue remodeling disorders are also provided.Type: GrantFiled: February 27, 2003Date of Patent: June 27, 2006Assignee: SmithKline Beecham Corp.Inventors: Robert Kirkpatrick, Martin Rosenberg
-
Publication number: 20060024299Abstract: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.Type: ApplicationFiled: July 21, 2005Publication date: February 2, 2006Applicants: Human Genome Sciences, Inc., SmithKline Beecham Corp.Inventors: Gregg Hastings, Mark Adams, Claire Fraser, Norman Lee, Ewen Kirkness, Judith Blake, Lisa Fitzgerald, Fred Drake, Maxine Gowan
-
Patent number: 6986745Abstract: A device having variable inspiratory resistance suitable for measuring the inspiratory strength of a patient which comprises a chamber in communication with a mouthpiece, said chamber (a) being provided with a calibration system for measuring the inhalation flow rate during inhalation through the mouthpiece and (b) being provided with a variable resistance feature by which the resistance to airflow through the device may be altered.Type: GrantFiled: July 3, 2002Date of Patent: January 17, 2006Assignee: Smithkline Beecham Corp.Inventors: Philip William Farr, Thomas Paul McCarthy
-
Publication number: 20050287177Abstract: A pharmaceutical composition comprising 3?-azido-3?-deoxythymidine and (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one suitable for once daily administrationType: ApplicationFiled: November 7, 2003Publication date: December 29, 2005Applicant: Glaxo Group Unlimited and Smithkline Beecham Corp.Inventors: Gary Goodson, Alison Floyd, Cecilia Navy
-
Publication number: 20050208618Abstract: ITGL-TSP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed Also disclosed are methods for utilizing ITGL-TSP polypeptides and polynucleotides in the design of protocols for the treatment of, angiogenic diseases (cancer, cancer metasis, chronic inflammatory disorders, rheumatoid arthritis, atherosclerosis, macular degeneration, diabetic retinopathy), restenosis, Alzheimer's disease and tissue remodeling, among others, and diagnostic assays for such conditions.Type: ApplicationFiled: January 15, 2004Publication date: September 22, 2005Applicants: Human Genome Sciences, Inc., SmithKline Beecham Corp.Inventors: Zdenka Jonak, Stephen Trulli, James Fornwald, Jonathon Terrett, Gregg Hastings
-
Patent number: 6936688Abstract: Human chemokine Beta-10 polypeptides and DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemokine polypeptides and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed.Type: GrantFiled: April 19, 2002Date of Patent: August 30, 2005Assignees: Human Genome Sciences, Inc., SmithKline Beecham Corp.Inventors: Henrik S. Olsen, Haodong Li, Mark D. Adams, Solange H. L. Gentz, Ralph Alderson, Yuling Li, David Parmelee, John R. White, Edward R. Appelbaum
-
Publication number: 20040187865Abstract: A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising fluticasone propionate or a physiologically acceptable solvate thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.Type: ApplicationFiled: April 14, 2004Publication date: September 30, 2004Applicant: SmithKline Beecham Corp.Inventors: Ian C. Ashurst, Ignatius Loy Britto, Craig Steven Herman, Li Li-Bovet, Michael Thomas Riebe
-
Publication number: 20040175794Abstract: ITGL-TSP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed Also disclosed are methods for utilizing ITGL-TSP polypeptides and polynucleotides in the design of protocols for the treatment of, angiogenic diseases (cancer, cancer metasis, chronic inflammatory disorders, rheumatoid arthritis, atherosclerosis, macular degeneration, diabetic retinopathy), restenosis, Alzheimer's disease and tissue remodeling, among others, and diagnostic assays for such conditions.Type: ApplicationFiled: January 15, 2004Publication date: September 9, 2004Applicants: Human Genome Sciences, Inc., SmithKline Beecham Corp.Inventors: Zdenka L. Jonak, Stephen H. Trulli, James A. Fornwald, Jonathon A. Terrett, Gregg A. Hastings
-
Publication number: 20040156822Abstract: Novel chemokines for mobilizing stem cells are provided. Methods of mobilizing stem cells are also provided.Type: ApplicationFiled: March 19, 2004Publication date: August 12, 2004Applicants: Human Genome Sciences, Inc., SmithKline Beecham Corp.Inventors: John R. White, Louis Pelus, Haodong Li, Brent L. Kreider
-
Publication number: 20040147527Abstract: This invention relates, in part, to newly identified methods of using quinolone antibiotics, particularly a gemifloxacin compound against certain pathogenic bacteria.Type: ApplicationFiled: January 15, 2004Publication date: July 29, 2004Applicant: SmithKline Beecham Corp.Inventors: Darrin Bast, Ross J. Davidson, Joyce DeAzavedo, Donald E. Low
-
Publication number: 20040126841Abstract: Human HL TEX11 polypeptides and DNA (RNA) encoding such HL TEX11 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such HL TEX11 for the treatment of atherosclerosis. inflammatory conditions. and infections. particularly viral infections such as AIDS. among others, among others. are also disclosed. Also disclosed are diagnostic assavs for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the HL TEX11 and for detecting altered levels of the polypeptide in a host.Type: ApplicationFiled: February 19, 2003Publication date: July 1, 2004Applicant: SmithKline Beecham Corp.Inventors: Winnie Chan, Derk J. Bergsma, Catherine E. Ellis
-
Publication number: 20040096888Abstract: 68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis; proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.Type: ApplicationFiled: October 6, 2003Publication date: May 20, 2004Applicant: SmithKline Beecham Corp.Inventors: Jeffrey Richard Jackson, Michael Joseph Hansbury
-
Publication number: 20030215847Abstract: Nucleic acid sequences for HC gp-39L are provided. Methods of detecting altered expression of tissue remodeling proteins and diagnosing tissue remodeling disorders are also provided.Type: ApplicationFiled: February 27, 2003Publication date: November 20, 2003Applicant: SmithKline Beecham Corp.Inventors: Robert B. Kirkpatrick, Martin Rosenberg
-
Patent number: H2153Abstract: Polymorphisms in the cysteinyl-leukotriene receptor 2 gene and their association with asthma are described.Type: GrantFiled: April 24, 2002Date of Patent: April 4, 2006Assignee: SmithKline Beecham Corp.Inventors: Diane Michele Ignar, Sreekumar Pillai
-
Patent number: D484591Type: GrantFiled: February 15, 2002Date of Patent: December 30, 2003Assignee: SmithKline Beecham Corp.Inventor: Paul Kenneth Rand
-
Patent number: D498840Type: GrantFiled: December 18, 2002Date of Patent: November 23, 2004Assignee: SmithKline Beecham Corp.Inventors: Michael L. King, Alan Ball, James Taylor Lloyd